Table 1.
Demographic and clinical characteristics of the primary APS cohort. All participants were of European-American ethnicity.
| Number | Age | Sex | Disease duration (yrs) | Antibody profile | Clinical characteristics |
|---|---|---|---|---|---|
| 1 | 33 | F | 5 | aCL | Pregnancy morbidity |
| 2 | 67 | M | 16 | aCL, LA | Venous and arterial thrombosis |
| 3 | 40 | F | 7 | aCL, LA | Arterial thrombosis, livedo reticularis, thrombocytopenia |
| 4 | 61 | M | 1 | aCL | Venous thrombosis |
| 5 | 37 | M | 12 | aB2G, aCL, LA | Arterial thrombosis, livedo reticularis |
| 6 | 36 | M | 15 | aB2G, aCL, LA | Venous and arterial thrombosis |
| 7 | 28 | F | 7 | aCL, LA | Pregnancy morbidity, venous thrombosis |
| 8 | 52 | M | 5 | aB2G, aCL, LA | Venous thrombosis |
| 9 | 40 | F | 1 | aB2G, aCL | Pregnancy morbidity, livedo reticularis, thrombocytopenia |
| 10 | 42 | F | 16 | aB2G, aCL, LA | Venous thrombosis |
aB2G, anti-beta2 glycoprotein I antibody; aCL, anti-cardiolipin antibody; LA, lupus anticoagulant.